Drs. Jacobsen and Heegaard contributed equally to this work.
1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Systemic Lupus Erythematosus
You have full text access to this OnlineOpen article
Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus
Article first published online: 27 SEP 2011
DOI: 10.1002/art.30499
Copyright © 2011 by the American College of Rheumatology
Additional Information
How to Cite
Nielsen, C. T., Østergaard, O., Johnsen, C., Jacobsen, S. and Heegaard, N. H. H. (2011), Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis & Rheumatism, 63: 3067–3077. doi: 10.1002/art.30499
- †
Drs. Jacobsen and Heegaard contributed equally to this work.
Publication History
- Issue published online: 27 SEP 2011
- Article first published online: 27 SEP 2011
- Accepted manuscript online: 23 JUN 2011 03:00PM EST
- Manuscript Accepted: 7 JUN 2011
- Manuscript Received: 13 NOV 2010
Funded by
- Danish Rheumatism Association. Grant Number: 233-527-17.10.05
- Lundbeck Foundation. Grant Number: 39/06
- Novo Nordisk Foundation. Grant Number: 5990
- Abstract
- Article
- References
- Cited By
Abstract
Objective
Characterization of the abundance, origin, and annexin V (AnxV)–binding capabilities of circulating microparticles (MPs) in SLE patients and healthy controls and to determine any associations with clinical parameters.
Methods
Seventy unselected SLE patients and 29 sex- and age-matched healthy control subjects were included in the study. MPs were isolated from citrate-treated plasma and characterized by flow cytometry using AnxV or antibodies to platelet, leukocyte, or endothelial cell surface markers.
Results
SLE patients had significantly increased concentrations of AnxV-nonbinding (AnxV−) MPs (P < 0.0001), while the concentrations of total MPs (P = 0.011) and AnxV-binding (AnxV+) MPs (P < 0.0001) were decreased, as compared with controls. Based on flow cytometric characteristics, 2 subgroups of AnxV− MPs could be discerned: AnxV− cell-derived MPs (CDMPs) and AnxV− MPs of unknown nature (UNMPs). Both fractions were significantly increased in SLE patients (P = 0.007 and P = 0.0018, respectively). Platelet- and leukocyte-derived MPs were decreased in the SLE patients (P < 0.0001), whereas no difference was observed for endothelial cell–derived MPs (P = 0.14). The concentrations of AnxV− CDMPs correlated with the concentrations of endothelial cell–derived MPs, the disease activity score, active nephritis, hypertension, history of arterial thrombosis, and triglyceride levels (P < 0.05 for all comparisons).
Conclusion
The concentrations and composition of MPs in SLE patients differ markedly from those in healthy subjects. Overall MP numbers were significantly decreased, but two distinct subpopulations of AnxV− MPs were significantly increased. These findings call for further characterization of MPs in SLE patients to elucidate their role in disease pathogenesis.